Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Reynolds

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Quality Assurance (San Diego, Calif.)|October 1, 1991
Cocarcinogenesis between cadmium and Aroclor 1254 in planarians is enhanced by inhibition of glutathione synthesisD J Schaeffer, W M Tehseen, L R Johnson, et al.
Journal of the American Veterinary Medical Association|December 1, 1989
Phase II evaluation of doxorubicin for treatment of various canine neoplasmsG K Ogilvie, H A Reynolds, R C Richardson, et al.
Journal of the American Veterinary Medical Association|December 1, 1989
Acute and short-term toxicoses associated with the administration of doxorubicin to dogs with malignant tumorsG K Ogilvie, R C Richardson, C R Curtis, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Quality Assurance (San Diego, Calif.)|October 1, 1991
Cocarcinogenesis between cadmium and Aroclor 1254 in planarians is enhanced by inhibition of glutathione synthesisD J Schaeffer, W M Tehseen, L R Johnson, et al.
Journal of the American Veterinary Medical Association|December 1, 1989
Phase II evaluation of doxorubicin for treatment of various canine neoplasmsG K Ogilvie, H A Reynolds, R C Richardson, et al.
Journal of the American Veterinary Medical Association|December 1, 1989
Acute and short-term toxicoses associated with the administration of doxorubicin to dogs with malignant tumorsG K Ogilvie, R C Richardson, C R Curtis, et al.
Pageof 2